The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s digestive and intestinal remedies market report forecasts the digestive and intestinal remedies market size to grow to $24.44 Billion by 2027, with a CAGR (compound annual growth rate) of more than 4%.

Learn More On The Digestive and Intestinal Remedies Market Report 2023 – https://www.thebusinessresearchcompany.com/report/digestive-and-intestinal-remedies-global-market-report

Digestive and Intestinal Remedies Market Size Forecast
The global digestive and intestinal remedies market is expected to grow from $19.49 billion in 2022 to $20.46 billion in 2023 at a compound annual growth rate (CAGR) of 4.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The digestive and intestinal remedies market size is expected to reach $24.44 billion in 2027 at a CAGR of 4.5%.

North America held the largest digestive and intestinal remedies market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Digestive and Intestinal Remedies Market Driver ­– Increase In Gastrointestinal Disorder Cases
For instance, in April 2020, according to a survey by the American Gastroenterological Association covering 33 countries on 6 continents regarding the prevalence of and factors associated with functional gastrointestinal disorders, among the 73,076 adult respondents, more than 40% of persons worldwide have FGIDs, which affect the quality of life and health care use. Additionally, in May 2020, News Medical, a UK-based open-access medical information company, said four people worldwide experience functional gastrointestinal diseases of varying severity for every 10 adults. Therefore, an increase in gastrointestinal disorder cases is expected to drive the digestive and intestinal remedy market.

Request for A Sample Of The Global Digestive and Intestinal Remedies Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8184&type=smp

Key Digestive and Intestinal Remedies Market Trend – Technological Developments And Advancements
Major players operating in the digestive and intestinal remedy market are focused on creating innovative technologies to manage and monitor digestive health in the digestive and intestinal remedy market. Recently the market has witnessed the use of breath analyzers to gather clinical condition information related to the digestive system. For instance, In May 2021, Owlstone Medical, a UK-based manufacturer and developer of breathalyzer for disease, launched digestive health breath testing in collaboration with functional gut diagnostics and functional gut clinic, providers of smart solutions for the diagnosis of gut health problems. Individuals can get better control over their digestive health through a simple at-home breath test. In SIBO and Food Intolerance, hydrogen and methane are well-established breath-based indicators. It uses an external substrate to create a precise and biologically relevant measurement of breath.

Digestive and Intestinal Remedies Market Segment
1) By Type: Digestive Medicines, Remedies Against Gastrointestinal Complaints, Natural And Synthetic Agents
2) By Age Group: Pediatric, Adults
3) By Distribution Channel: Online, Offline

Digestive and Intestinal Remedies Market Major Players and Strategies
Major players in the digestive and intestinal remedies market are Bayer AG, Johnson & Johnson, GlaxoSmithKline Plc., Procter & Gamble Company, Sanofi SA, CH Boehringer Sohn AG & Co KG, Reckitt Benckiser Group plc, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Menarini Group, Bausch Health Companies Inc., Eli Lilly and Company, Jiangzhong Pharmaceutical Co Ltd., Merck KGaA, Pfizer Inc., and Prestige Consumer Healthcare Inc.

In February 2020, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, acquired PVP Biologics, Inc. for $300 million. Through this acquisition, Takeda increased its targeted therapy-based product portfolio for digestive diseases and research and development capabilities in the field of gastrointestinal disorders. PVP Biologics, Inc. is a US-based pharmaceutical company specializing in developing medicines for treating digestive and intestinal remedies diseases.

The Digestive and Intestinal Remedies Global Market Report 2023 covers regional data on digestive and intestinal remedies market size, digestive and intestinal remedies market trends and drivers, opportunities, strategies, and digestive and intestinal remedies market competitor analysis. The countries covered in the digestive and intestinal remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The digestive and intestinal remedy refers to medications that can treat gastrointestinal disorders such as stomach upset, constipation, and diarrhoea. It uses classes of drugs such as antacids, proton pump inhibitors, and histamine2 blockers during the treatment process.

View More Reports Related To The Digestive and Intestinal Remedies Market –
Digestive Enzymes Global Market Report 2023
Digestive Health Supplements Global Market Report 2023
Digestive Health Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: